KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Payables (2016 - 2025)

Historic Payables for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $48.1 million.

  • Chemed's Payables rose 702.52% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.1 million, marking a year-over-year increase of 702.52%. This contributed to the annual value of $44.1 million for FY2024, which is 3105.85% down from last year.
  • Latest data reveals that Chemed reported Payables of $48.1 million as of Q3 2025, which was up 702.52% from $50.9 million recorded in Q2 2025.
  • Chemed's Payables' 5-year high stood at $77.2 million during Q3 2022, with a 5-year trough of $40.3 million in Q1 2023.
  • For the 5-year period, Chemed's Payables averaged around $54.7 million, with its median value being $55.4 million (2021).
  • In the last 5 years, Chemed's Payables soared by 5290.31% in 2021 and then crashed by 4449.75% in 2023.
  • Quarter analysis of 5 years shows Chemed's Payables stood at $73.0 million in 2021, then crashed by 42.64% to $41.9 million in 2022, then surged by 52.88% to $64.0 million in 2023, then plummeted by 31.06% to $44.1 million in 2024, then increased by 8.95% to $48.1 million in 2025.
  • Its Payables was $48.1 million in Q3 2025, compared to $50.9 million in Q2 2025 and $47.7 million in Q1 2025.